Reliance Chemotex Industries Ltd

MD re-appointment

• Reason: Re-appointment as Managing Director for a 3-year term (Sept 1, 2026–Aug 31, 2029).
• Effective from September 1, 2026; shareholder approval required.
• Profile: joined in 1983; MD since 1988.
• Relatives: Rahul Shroff and Ameya Shroff are sons and Whole-time Directors.
• Not debarred from holding director office by SEBI.
• Shareholders' approval required for re-appointment.

Book closure and notice

• Register of Members and share transfer books closed Sep 18–24, 2026 (inclusive) for the AGM.
• Security type: Equity shares.

Record date and dividend

• Record date for AGM and dividend entitlement: Sep 18, 2026.
• Dividend for FY ended 31-Mar-2026 payable to holders on the record date.

E-voting

• E-voting window: 21–23 Sep 2026, 09:00–17:00 IST.

Financial results and governance filings

• Unaudited standalone quarterly results for quarter ended 30 June 2026 approved; Limited Review Report issued.
• Board's Report with annexures for FY ended 31 March 2026 approved.
• Notice of 48th AGM to be held on 24 September 2026 via VC/OAVM approved.
• Register of Members and Share Transfer Books to close 18–24 September 2026.
• Record date for AGM and dividend fixed as 18 September 2026.
• Cut-off date 18 September 2026; remote e-voting 21–23 September 2026.
• Appointment of M/s Ronak Jhuthawat & Co. as Scrutinizer for AGM.
• Limited Review Report notes no material misstatement.

MD appointment and related governance

• Sanjiv Shroff re-appointed as MD for 3 years from 1 Sep 2026, subject to shareholders' approval.
• MD term ends 31 August 2029.

Financials

• Total Income (quarter ended 30 Jun 2026): 9,971.51; YoY growth 7.5% vs 9,275.42.
• Profit before tax: 129.98; Net profit: 136.65.
• EPS (Basic & Diluted, not annualised): 2.31.
• Raw materials consumed: 5,413.00.
• Changes in inventories: (805.10).
• Employee benefits expense: 1,714.83.
• Finance cost: 676.45.
• Depreciation and amortisation: 363.46.
• Power and fuel: 117.21.
• Other expenses: 130.67.
• Total Expenses: 9,841.53.
• Primary segment: Yarn; single reportable segment.
• Trading window closed till Aug 13, 2026 for designated persons.
• Board approved unaudited results; Limited Review by PKMB & Co.

Dematerialisation processing and listing

• Dematerialisation requests for the quarter were confirmed to depositories.
• Securities dematerialised have been listed on the stock exchanges.
• Physical certificates for dematerialisation were mutilated and cancelled; depository name substituted within 15 days.

Internal auditor

• M/s. Rajeev Amitabh & Co. re-appointed as Internal Auditor for FY 2026-27.
• Re-appointment approved on May 29, 2026.
• Firm founded in 1990; audits listed, public, and private companies.
• Has experience in taxation and management consultancy.

Cost auditor

• M/s. N N & Associates re-appointed as Cost Auditor for FY 2026-27.
• Re-appointment approved on May 29, 2026.
• Firm founded in 2018 by Shri Naresh Kumar Goel.
• Experienced across chemicals, FMCG, metals, power, textiles, and other industries.

Costs and margins

• 📊 Q4 FY26 revenue from operations rose 7.3% YoY to Rs 8,817.66 lakh.
• 📊 FY26 revenue from operations increased 1.0% YoY to Rs 36,200.58 lakh.
• 📊 Q4 FY26 total income was Rs 9,085.37 lakh, up 8.3% YoY.
• 📊 FY26 total income was Rs 36,583.52 lakh, down 0.8% YoY.
• 📊 Q4 FY26 PBT was Rs 173.85 lakh versus Rs 302.90 lakh last year.
• 📊 FY26 PBT rose 32.4% YoY to Rs 484.05 lakh.
• 📊 Q4 FY26 PAT was Rs 174.59 lakh, down 5.1% YoY.
• 📊 FY26 PAT increased 30.1% YoY to Rs 526.15 lakh.
• 📊 FY26 total comprehensive income rose to Rs 584.26 lakh from Rs 438.82 lakh.
• 📊 Basic and diluted EPS for FY26 was Rs 6.97 versus Rs 5.36 last year.

Balance sheet and cash flow

• 📊 Raw material cost was Rs 18,798.12 lakh in FY26, broadly flat YoY.
• 📊 Employee benefit expense rose to Rs 6,774.57 lakh in FY26.
• 📊 Finance cost increased to Rs 2,490.48 lakh in FY26.
• 📊 Power and fuel expense rose to Rs 4,607.51 lakh in FY26.
• 📊 Other expenses declined to Rs 4,555.98 lakh in FY26.
• 📊 FY26 included Rs 230.75 lakh government grant income.
• 📊 FY26 deferred tax liability reversal of Rs 77.23 lakh was recognized.

Dividend and audit

• 📊 Total assets increased to Rs 51,195.78 lakh as of March 31, 2026.
• 📊 Inventories rose to Rs 9,948.56 lakh from Rs 6,915.24 lakh.
• 📊 Trade receivables fell to Rs 960.50 lakh from Rs 1,755.04 lakh.
• 📊 Borrowings totaled Rs 26,687.40 lakh, including Rs 14,644.40 lakh long-term.
• 📊 Cash and cash equivalents were Rs 40.51 lakh at year-end.
• 📊 FY26 operating cash flow was Rs 2,164.72 lakh.
• 📊 FY26 investing cash flow was negative Rs 184.85 lakh.
• 📊 FY26 financing cash flow was negative Rs 1,997.35 lakh.

Operations and business

• 📍 Board recommended a final dividend of 5%, or Rs 0.50 per share.
• 📍 Dividend aggregates to Rs 37.72 lakh for FY26.
• 📍 Statutory auditor issued an unmodified opinion on the standalone results.

Operations and business

• 🗒️ The company reported only one reportable primary business segment.
• 🗒️ Results were approved by the Board on May 29, 2026.

Meeting Details

• Board meeting scheduled for Friday, May 29, 2026, through video conferencing.

Key Agenda Items

• Approve audited financial results for quarter and year ended March 31, 2026.
• Review statement of assets and liabilities as at March 31, 2026.
• Review cash flow statement for year ended March 31, 2026.
• Take on record the auditor’s report on the audited results.
• Recommend final dividend, if any, for equity shares for FY 2025-26.

Other Notes

• Trading window remains closed from April 1, 2026 until May 31, 2026.